| PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors F Meric-Bernstam, A Akcakanat, H Chen, KA Do, T Sangai, F Adkins, ... Clinical cancer research 18 (6), 1777-1789, 2012 | 232 | 2012 |
| Triple-negative breast cancer and obesity in a rural Appalachian population L Vona-Davis, DP Rose, H Hazard, M Howard-McNatt, F Adkins, J Partin, ... Cancer Epidemiology Biomarkers & Prevention 17 (12), 3319-3324, 2008 | 198 | 2008 |
| Triple-negative breast cancer is not a contraindication for breast conservation FC Adkins, AM Gonzalez-Angulo, X Lei, LF Hernandez-Aya, EA Mittendorf, ... Annals of surgical oncology 18, 3164-3173, 2011 | 128 | 2011 |
| Small bowel obstruction KL Bower, DI Lollar, SL Williams, FC Adkins, DT Luyimbazi, CE Bower Surgical Clinics 98 (5), 945-971, 2018 | 92 | 2018 |
| Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors B Hassan, A Akcakanat, T Sangai, KW Evans, F Adkins, AK Eterovic, ... Oncotarget 5 (18), 8544, 2014 | 69 | 2014 |
| Epithelial to mesenchymal transition is associated with rapamycin resistance AM Holder, A Akcakanat, F Adkins, K Evans, H Chen, C Wei, DR Milton, ... Oncotarget 6 (23), 19500, 2015 | 27 | 2015 |
| In vitro effects of pentosan polysulfate against malignant breast cells S Zaslau, DR Riggs, BJ Jackson, FC Adkins, CC John, SJ Kandzari, ... The American journal of surgery 188 (5), 589-592, 2004 | 26 | 2004 |
| Opioid prescribing practices during implementation of an enhanced recovery program at a tertiary care hospital AW Gerrish, S Fogel, ER Lockhart, M Nussbaum, F Adkins Surgery 164 (4), 674-679, 2018 | 22 | 2018 |
| Triple-negative breast cancer and obesity in a rural Appalachian population. L Vona-Davis, DP Rose, H Hazard, J Partin, F Adkins, G Hobbs Cancer Research 69 (2_Supplement), 6099, 2009 | 1 | 2009 |
| Robotic Right Hemicolectomy for Tubulovillous Adenoma with High-Grade Dysplasia: Multimedia Analysis of a Contemporary Technique F Adkins Journal of Medical Insight 2023 (2), 2023 | | 2023 |
| CENTRAL SURGICAL ASSOCIATION FA Luchette, CA Miller, WC Cirocco, EC Ellison, AN Cobb, AJ Benjamin, ... Surgery, A3, 2018 | | 2018 |
| MINIMALLY INVASIVE TECHNIQUES IMPROVE OUTCOMES FOR TREATMENT OF COLOVAGINAL FISTULA. HL Warren, J Patel, MS Nussbaum, F Adkins DISEASES OF THE COLON & RECTUM 61 (5), E216-E217, 2018 | | 2018 |
| mTOR inhibitor MLN0128 Has antitumor efficacy in cell lines with intrinsic and acquired rapamycin resistance in vitro and in vivo. B Hassan, A Akcakanat, T Sangai, F Adkins, K Evans, GB Mills, ... Cancer Research 73 (8_Supplement), 2448-2448, 2013 | | 2013 |
| Epithelial to mesenchymal transition and rapamycin sensitivity in cancer cell lines. AM Holder, F Adkins, A Akcakanat, H Chen, KA Do, MC Hung, ... Cancer Research 73 (8_Supplement), 1496-1496, 2013 | | 2013 |
| MTOR Inhibitor MLN0128 has Antitumor Efficacy in Cell Lines With Intrinsic and Acquired Rapamycin-Resistance. B Hassan, A Akcakanat, S Takafumi, K Evans, F Adkins, F Meric-Bernstam Journal of Surgical Research 179 (2), 313, 2013 | | 2013 |
| Epithelial-mesenchymal transition confers resistance to rapamycin F Adkins, A Akcakanat, H Chen, KA Do, AM Gonzalez-Angulo, G Mills, ... Journal of the American College of Surgeons 213 (3), S144, 2011 | | 2011 |
| Differential Regulation Of Tumor Suppressor PDCD4 Expression By Rapamycin F Adkins, W Kim, A Akcakanat, G Singh, M Hung, F Meric-Bernstam Journal of Surgical Research 2 (165), 178, 2011 | | 2011 |
| Triple-negative breast cancer and obesity in a rural Appalachian population L Vena-Davis, DP Rose, H Hazard, J Partin, F Adkins, G Hobbs CANCER RESEARCH 69 (2), 376S-376S, 2009 | | 2009 |
| Phenotypic characteristics of basal-like breast cancer in rural Appalachia M Howard-McNatt, H Hazard, F Adkins, L Vona-Davis Cancer Epidemiology Biomarkers & Prevention 16 (11_Supplement), A72-A72, 2007 | | 2007 |
